These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

532 related items for PubMed ID: 19539096

  • 1. Treatment of depression in the elderly: a review of the recent literature on the efficacy of single- versus dual-action antidepressants.
    Mukai Y, Tampi RR.
    Clin Ther; 2009 May; 31(5):945-61. PubMed ID: 19539096
    [Abstract] [Full Text] [Related]

  • 2. Clinical utility of desvenlafaxine 50 mg/d for treating MDD: a review of two randomized placebo-controlled trials for the practicing physician.
    Reddy S, Kane C, Pitrosky B, Musgnung J, Ninan PT, Guico-Pabia CJ.
    Curr Med Res Opin; 2010 Jan; 26(1):139-50. PubMed ID: 19919295
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Antidepressants versus placebo for depression in primary care.
    Arroll B, Elley CR, Fishman T, Goodyear-Smith FA, Kenealy T, Blashki G, Kerse N, Macgillivray S.
    Cochrane Database Syst Rev; 2009 Jul 08; 2009(3):CD007954. PubMed ID: 19588448
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Efficacy and tolerability of tricyclic antidepressants and SSRIs compared with placebo for treatment of depression in primary care: a meta-analysis.
    Arroll B, Macgillivray S, Ogston S, Reid I, Sullivan F, Williams B, Crombie I.
    Ann Fam Med; 2005 Jul 08; 3(5):449-56. PubMed ID: 16189062
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. A systematic review of antidepressant placebo-controlled trials for geriatric depression: limitations of current data and directions for the future.
    Taylor WD, Doraiswamy PM.
    Neuropsychopharmacology; 2004 Dec 08; 29(12):2285-99. PubMed ID: 15340391
    [Abstract] [Full Text] [Related]

  • 10. WITHDRAWN: Selective serotonin reuptake inhibitors (SSRIs) versus other antidepressants for depression.
    Geddes JR, Freemantle N, Mason J, Eccles MP, Boynton J.
    Cochrane Database Syst Rev; 2007 Jul 18; 2006(3):CD001851. PubMed ID: 17636689
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Milnacipran and selective serotonin reuptake inhibitors in major depression.
    Lopez-Ibor J, Guelfi JD, Pletan Y, Tournoux A, Prost JF.
    Int Clin Psychopharmacol; 1996 Sep 18; 11 Suppl 4():41-6. PubMed ID: 8923126
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Selective serotonin reuptake inhibitors versus tricyclic antidepressants in young patients: a meta-analysis of efficacy and acceptability.
    Qin B, Zhang Y, Zhou X, Cheng P, Liu Y, Chen J, Fu Y, Luo Q, Xie P.
    Clin Ther; 2014 Jul 01; 36(7):1087-1095.e4. PubMed ID: 24998011
    [Abstract] [Full Text] [Related]

  • 18. Meta-analytical studies on new antidepressants.
    Anderson IM.
    Br Med Bull; 2001 Jul 01; 57():161-78. PubMed ID: 11719915
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.